BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10566160)

  • 1. [Benign endometrial lesions induced by tamoxifen].
    De Muylder X
    J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):420-4. PubMed ID: 10566160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
    J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some specifics of tamoxifen's effect on the endometrium in menopausal cancer patients].
    Ashtrafian LA; Antonova IB; Chazova NL; Motskobili TA; Babaeva NA; Al'ditskiĭ IA
    Vopr Onkol; 2005; 51(2):200-5. PubMed ID: 16223001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial tubal metaplasia in a young puerperal woman after breast cancer.
    Di Benedetto L; Giovanale V; Caserta D
    Int J Clin Exp Pathol; 2015; 8(6):7610-3. PubMed ID: 26261678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
    Lee M; Piao J; Jeon MJ
    Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen induced endometrial abnormalities: evaluation by saline infusion sonohysterography.
    Jaeger BM; Grumbach K
    Md Med J; 1997 Sep; 46(8):433-5. PubMed ID: 9294952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy].
    d'Arailh AS; Michy T; Pioud R; Dravet F; Classe JM
    Gynecol Obstet Fertil; 2007 Dec; 35(12):1215-9. PubMed ID: 18035581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endometrial cancers arising in polyps associated with tamoxifen use].
    Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
    Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
    McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
    Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD; Aydin Y; Atis A; Mandiraci G
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tamoxifen and giant endometrial polyps].
    Caschetto S; Cassaro N; Consalvo P; Caragliano L
    Minerva Ginecol; 2000 Nov; 52(11):459-63. PubMed ID: 11256174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-induced hyperplasia of the endometrium.
    Neis KJ; Brandner P; Schlenker M
    Contrib Gynecol Obstet; 2000; 20():60-8. PubMed ID: 11791286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the endometrial pathology using flexible ambulatory hysteroscopy of patients treated with Tamoxifen].
    Kuzmanov B
    Akush Ginekol (Sofiia); 2004; 43(3):32-3. PubMed ID: 15341254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-induced uterine abnormalities: the role of imaging.
    Ascher SM; Imaoka I; Lage JM
    Radiology; 2000 Jan; 214(1):29-38. PubMed ID: 10644098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.